109 related articles for article (PubMed ID: 38870176)
1. Glyoxalase 1: Emerging biomarker and therapeutic target in cervical cancer progression.
Kim JY; Jung JH; Jung S; Lee S; Lee HA; Ouh YT; Hong SH
PLoS One; 2024; 19(6):e0299345. PubMed ID: 38870176
[TBL] [Abstract][Full Text] [Related]
2. Selective activation of apoptosis program by S-p-bromobenzylglutathione cyclopentyl diester in glyoxalase I-overexpressing human lung cancer cells.
Sakamoto H; Mashima T; Sato S; Hashimoto Y; Yamori T; Tsuruo T
Clin Cancer Res; 2001 Aug; 7(8):2513-8. PubMed ID: 11489834
[TBL] [Abstract][Full Text] [Related]
3. Emerging Glycation-Based Therapeutics-Glyoxalase 1 Inducers and Glyoxalase 1 Inhibitors.
Rabbani N; Thornalley PJ
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269594
[TBL] [Abstract][Full Text] [Related]
4. Glo1 genetic amplification as a potential therapeutic target in hepatocellular carcinoma.
Zhang S; Liang X; Zheng X; Huang H; Chen X; Wu K; Wang B; Ma S
Int J Clin Exp Pathol; 2014; 7(5):2079-90. PubMed ID: 24966916
[TBL] [Abstract][Full Text] [Related]
5. Glyoxalase I in tumor cell proliferation and survival and as a potential target for anticancer therapy.
Geng X; Ma J; Zhang F; Xu C
Oncol Res Treat; 2014; 37(10):570-4. PubMed ID: 25342507
[TBL] [Abstract][Full Text] [Related]
6. Glyoxalase-I is a novel prognosis factor associated with gastric cancer progression.
Cheng WL; Tsai MM; Tsai CY; Huang YH; Chen CY; Chi HC; Tseng YH; Chao IW; Lin WC; Wu SM; Liang Y; Liao CJ; Lin YH; Chung IH; Chen WJ; Lin PY; Wang CS; Lin KH
PLoS One; 2012; 7(3):e34352. PubMed ID: 22479608
[TBL] [Abstract][Full Text] [Related]
7. High expression of GLO1 indicates unfavorable clinical outcomes in glioma patients.
Tian X; Wang Y; Ding X; Cheng W
J Neurosurg Sci; 2022 Jun; 66(3):228-233. PubMed ID: 31738028
[TBL] [Abstract][Full Text] [Related]
8. Multiple roles of glyoxalase 1-mediated suppression of methylglyoxal glycation in cancer biology-Involvement in tumour suppression, tumour growth, multidrug resistance and target for chemotherapy.
Rabbani N; Xue M; Weickert MO; Thornalley PJ
Semin Cancer Biol; 2018 Apr; 49():83-93. PubMed ID: 28506645
[TBL] [Abstract][Full Text] [Related]
9. GLO1-A novel amplified gene in human cancer.
Santarius T; Bignell GR; Greenman CD; Widaa S; Chen L; Mahoney CL; Butler A; Edkins S; Waris S; Thornalley PJ; Futreal PA; Stratton MR
Genes Chromosomes Cancer; 2010 Aug; 49(8):711-25. PubMed ID: 20544845
[TBL] [Abstract][Full Text] [Related]
10. Modulation of GLO1 Expression Affects Malignant Properties of Cells.
Hutschenreuther A; Bigl M; Hemdan NY; Debebe T; Gaunitz F; Birkenmeier G
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27999356
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of GLO1 in Glioblastoma Multiforme Increases DNA-AGEs, Stimulates RAGE Expression, and Inhibits Brain Tumor Growth in Orthotopic Mouse Models.
Jandial R; Neman J; Lim PP; Tamae D; Kowolik CM; Wuenschell GE; Shuck SC; Ciminera AK; De Jesus LR; Ouyang C; Chen MY; Termini J
Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29385725
[TBL] [Abstract][Full Text] [Related]
12. Glyoxalase 1 is up-regulated in hepatocellular carcinoma and is essential for HCC cell proliferation.
Hu X; Yang X; He Q; Chen Q; Yu L
Biotechnol Lett; 2014 Feb; 36(2):257-63. PubMed ID: 24158671
[TBL] [Abstract][Full Text] [Related]
13. Integrated genomic and functional analyses reveal glyoxalase I as a novel metabolic oncogene in human gastric cancer.
Hosoda F; Arai Y; Okada N; Shimizu H; Miyamoto M; Kitagawa N; Katai H; Taniguchi H; Yanagihara K; Imoto I; Inazawa J; Ohki M; Shibata T
Oncogene; 2015 Feb; 34(9):1196-206. PubMed ID: 24662817
[TBL] [Abstract][Full Text] [Related]
14. LncRNA OIP5-AS1 Promotes Breast Cancer Progression by Regulating miR-216a-5p/GLO1.
Wu Z; Liu Y; Wei L; Han M
J Surg Res; 2021 Jan; 257():501-510. PubMed ID: 32916503
[TBL] [Abstract][Full Text] [Related]
15. GLO1 overexpression in human malignant melanoma.
Bair WB; Cabello CM; Uchida K; Bause AS; Wondrak GT
Melanoma Res; 2010 Apr; 20(2):85-96. PubMed ID: 20093988
[TBL] [Abstract][Full Text] [Related]
16. Glyoxalase 1 (GLO1) Inhibition or Genetic Overexpression Does Not Alter Ethanol's Locomotor Effects: Implications for GLO1 as a Therapeutic Target in Alcohol Use Disorders.
Barkley-Levenson AM; Lagarda FA; Palmer AA
Alcohol Clin Exp Res; 2018 May; 42(5):869-878. PubMed ID: 29532486
[TBL] [Abstract][Full Text] [Related]
17. miR-137 inhibits melanoma cell proliferation through downregulation of GLO1.
Lv N; Hao S; Luo C; Abukiwan A; Hao Y; Gai F; Huang W; Huang L; Xiao X; Eichmüller SB; He D
Sci China Life Sci; 2018 May; 61(5):541-549. PubMed ID: 29307109
[TBL] [Abstract][Full Text] [Related]
18. Glyoxalase I (GLO1) is up-regulated in pancreatic cancerous tissues compared with related non-cancerous tissues.
Wang Y; Kuramitsu Y; Ueno T; Suzuki N; Yoshino S; Iizuka N; Akada J; Kitagawa T; Oka M; Nakamura K
Anticancer Res; 2012 Aug; 32(8):3219-22. PubMed ID: 22843895
[TBL] [Abstract][Full Text] [Related]
19. Methylglyoxal, a glycolysis metabolite, triggers metastasis through MEK/ERK/SMAD1 pathway activation in breast cancer.
Nokin MJ; Bellier J; Durieux F; Peulen O; Rademaker G; Gabriel M; Monseur C; Charloteaux B; Verbeke L; van Laere S; Roncarati P; Herfs M; Lambert C; Scheijen J; Schalkwijk C; Colige A; Caers J; Delvenne P; Turtoi A; Castronovo V; Bellahcène A
Breast Cancer Res; 2019 Jan; 21(1):11. PubMed ID: 30674353
[TBL] [Abstract][Full Text] [Related]
20. Exploring glyoxalase 1 expression in prostate cancer tissues: targeting the enzyme by ethyl pyruvate defangs some malignancy-associated properties.
Baunacke M; Horn LC; Trettner S; Engel KM; Hemdan NY; Wiechmann V; Stolzenburg JU; Bigl M; Birkenmeier G
Prostate; 2014 Jan; 74(1):48-60. PubMed ID: 24105621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
